Order Article Reprints

Duangdara J, Boonsri B, Sayinta A, Supradit K, Thintharua P, Kumkate S, Suriyonplengsaeng C, Larbcharoensub N, Mingphruedhi S, Rungsakulkij N, et al. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals. 2024; 17(1):9. https://doi.org/10.3390/ph17010009

Duangdara, Jinchutha, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij, and et al. 2024. "CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS" Pharmaceuticals 17, no. 1: 9. https://doi.org/10.3390/ph17010009

Duangdara, J., Boonsri, B., Sayinta, A., Supradit, K., Thintharua, P., Kumkate, S., Suriyonplengsaeng, C., Larbcharoensub, N., Mingphruedhi, S., Rungsakulkij, N., Muangkaew, P., Tangtawee, P., Vassanasiri, W., Suragul, W., Janvilisri, T., Tohtong, R., Bates, D. O., & Wongprasert, K. (2024). CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals, 17(1), 9. https://doi.org/10.3390/ph17010009